799 related articles for article (PubMed ID: 19805650)
1. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ
Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650
[TBL] [Abstract][Full Text] [Related]
2. Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) Study.
Ariesen MJ; Tangelder MJ; Lawson JA; Eikelboom BC; Grobbee DE; Algra A;
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):154-9. PubMed ID: 15996602
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
Pengo V; Legnani C; Noventa F; Palareti G;
Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
[TBL] [Abstract][Full Text] [Related]
6. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
Kasner SE; Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Benesch CG; Sila CA; Jovin TG; Romano JG; Cloft HJ;
Circulation; 2006 Jan; 113(4):555-63. PubMed ID: 16432056
[TBL] [Abstract][Full Text] [Related]
7. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin as a marker for bleeding complications during warfarin treatment.
Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH
Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070
[TBL] [Abstract][Full Text] [Related]
10. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
[TBL] [Abstract][Full Text] [Related]
11. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
12. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study.
Hellings WE; Peeters W; Moll FL; Piers SR; van Setten J; Van der Spek PJ; de Vries JP; Seldenrijk KA; De Bruin PC; Vink A; Velema E; de Kleijn DP; Pasterkamp G
Circulation; 2010 May; 121(17):1941-50. PubMed ID: 20404256
[TBL] [Abstract][Full Text] [Related]
13. Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).
Aronow HD; Califf RM; Harrington RA; Vallee M; Graffagnino C; Shuaib A; Fitzgerald DJ; Easton JD; Van de Werf F; Diener HC; Ferguson J; Koudstaal PJ; Amarenco P; Theroux P; Davis S; Topol EJ
Am J Cardiol; 2008 Nov; 102(10):1285-90. PubMed ID: 18993142
[TBL] [Abstract][Full Text] [Related]
14. Risks of oral anticoagulant therapy with increasing age.
Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
[TBL] [Abstract][Full Text] [Related]
15. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
[TBL] [Abstract][Full Text] [Related]
17. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction.
Azar AJ; Koudstaal PJ; Wintzen AR; van Bergen PF; Jonker JJ; Deckers JW
Ann Neurol; 1996 Mar; 39(3):301-7. PubMed ID: 8602748
[TBL] [Abstract][Full Text] [Related]
18. The impact of peripheral vascular disease on long-term survival after coronary artery bypass graft surgery.
Chu D; Bakaeen FG; Wang XL; Dao TK; LeMaire SA; Coselli JS; Huh J
Ann Thorac Surg; 2008 Oct; 86(4):1175-80. PubMed ID: 18805156
[TBL] [Abstract][Full Text] [Related]
19. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
[TBL] [Abstract][Full Text] [Related]
20. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
